Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bimiralisib by Torqur for Actinic (Solar) Keratosis: Likelihood of Approval
Bimiralisib is under clinical development by Torqur and currently in Phase II for Actinic (Solar) Keratosis. According to GlobalData, Phase...